1. Human molybdenum exposure risk in industrial regions of China: New critical effect indicators and reference dose
- Author
-
Hong-Xuan Kuang, Meng-Yang Li, Xiao-Wen Zeng, Da Chen, Yang Zhou, Tong Zheng, Ming-Deng Xiang, Qi-Zhen Wu, Xi-Chao Chen, Guang-Hui Dong, and Yun-Jiang Yu
- Subjects
Metals ,Cystatin-C ,Chronic kidney disease ,Bayesian Benchmark Dose ,Guidance values ,Environmental pollution ,TD172-193.5 ,Environmental sciences ,GE1-350 - Abstract
Evidence increasingly suggests molybdenum exposure at environmental levels is still associated with adverse human health, emphasizing the necessity to establish a more protective reference dose (RfD). Herein, we conducted a study measuring 15 urinary metals and 30 clinical health indicators in 2267 participants residing near chemical enterprises across 11 Chinese provinces to investigate their relationships. The kidney and cystatin-C emerged as the most sensitive organ and critical effect indicator of molybdenum exposure, respectively. Odds of cystatin-C-defined chronic kidney disease (CKD) in the highest quantile of molybdenum exposure significantly increased by 133.5% (odds ratio [OR]: 2.34, 95% CI: 1.78, 3.11) and 75.8% (OR: 1.76, 95% CI: 1.24, 2.49) before and after adjusting for urinary 14 metals, respectively. Intriguingly, cystatin-C significantly mediated 15.9–89.5% of molybdenum's impacts on liver and lung function, suggesting nephrotoxicity from molybdenum exposure may trigger hepatotoxicity and pulmonary toxicity. We derived a new RfD for molybdenum exposure (0.87 μg/kg-day) based on cystatin-C-defined estimated glomerular filtration rate by employing Bayesian Benchmark Dose modeling analysis. This RfD is significantly lower than current exposure guidance values (5–30 μg/kg-day). Remarkably, >90% of participants exceeded the new RfD, underscoring the significant health impacts of environmental molybdenum exposure on populations in industrial regions of China.
- Published
- 2024
- Full Text
- View/download PDF